Waddell Elizabeth Needham, Messeri Peter A
Department of Population and Family Health, Mailman School of Public Health, Columbia University, New York, NY, USA.
AIDS Behav. 2006 May;10(3):263-72. doi: 10.1007/s10461-005-9042-x.
This paper investigates the association between social support, disclosure of HIV/AIDS, and odds of initiating combination antiretroviral drug therapy in its first years on the market. Data are drawn from the first three rounds of the Community Health Advisory and Information Network (CHAIN) survey, collected between 1994 and 1997. CHAIN documents service needs and rates of service utilization among a representative sample of persons with HIV/AIDS in New York City. A two-step logistic regression estimated associations between (1) perceived social support and use of combination antiretroviral therapy, and (2) the interaction between concealing HIV/AIDS and perceived social support. Results offered evidence that the positive association between social support and use of highly active antiretroviral treatment (HAART) and other combination antiretroviral therapies is contingent upon disclosure of HIV status within the household or among friend and acquaintance networks. A positive association between social support and odds of using combination therapy was only observed among those who disclosed their HIV status.
本文探讨了社会支持、艾滋病毒/艾滋病的披露与抗逆转录病毒联合药物疗法上市头几年开始使用该疗法的几率之间的关联。数据取自1994年至1997年期间进行的社区健康咨询与信息网络（CHAIN）调查的前三轮。CHAIN记录了纽约市具有代表性的艾滋病毒/艾滋病患者样本中的服务需求和服务利用率。采用两步逻辑回归估计（1）感知到的社会支持与抗逆转录病毒联合疗法的使用之间的关联，以及（2）隐瞒艾滋病毒/艾滋病与感知到的社会支持之间的相互作用。结果表明，社会支持与高效抗逆转录病毒治疗（HAART）及其他抗逆转录病毒联合疗法的使用之间呈正相关，这取决于在家庭内部或朋友及熟人网络中披露艾滋病毒感染状况。社会支持与使用联合疗法几率之间的正相关仅在那些披露了其艾滋病毒感染状况的人群中观察到。
